BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3119546)

  • 21. New antimetastatic hypoxic cell radiosensitizers: design, synthesis, and biological activities of 2-nitroimidazole-acetamide, TX-1877, and its analogues.
    Kasai S; Nagasawa H; Yamashita M; Masui M; Kuwasaka H; Oshodani T; Uto Y; Inomata T; Oka S; Inayama S; Hori H
    Bioorg Med Chem; 2001 Feb; 9(2):453-64. PubMed ID: 11249137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure and antitumor activity relationship of 2-arylidene-4-cyclopentene-1, 3-diones and 2-arylideneindan-1, 3-diones.
    Inayama S; Mamoto K; Shibata T; Hirose T
    J Med Chem; 1976 Mar; 19(3):433-6. PubMed ID: 1255669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of arylidene-cyclopentenedione radiosensitizers on ATP synthesis in mitochondria: action as potent inhibitors of phosphate transport.
    Koike H; Hori H; Inayama S; Terada H
    Biochem Biophys Res Commun; 1988 Sep; 155(2):1066-74. PubMed ID: 3421958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiosensitizing hypoxic cells with new 3-nitro-1,2,4-triazole derivatives in vitro and in vivo.
    Nagao Y; Sano S; Ochiai M; Fuji K; Nishimoto S; Kagiya T; Murayama C; Mori T; Shibamoto Y; Sasai K
    Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1951-3. PubMed ID: 2805177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia-selective antitumor agents. 6. 4-(Alkylamino)nitroquinolines: a new class of hypoxia-selective cytotoxins.
    Denny WA; Atwell GJ; Roberts PB; Anderson RF; Boyd M; Lock CJ; Wilson WR
    J Med Chem; 1992 Dec; 35(26):4832-41. PubMed ID: 1479583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitroimidazole-based bioreductive compounds bearing a quinazoline or a naphthyridine chromophore.
    Papadopoulou MV; Bloomer WD
    Anticancer Drugs; 2009 Jul; 20(6):493-502. PubMed ID: 19430289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential radiosensitizing agents. 5. 2-Substituted benzimidazole derivatives.
    Gupta RP; Larroquette CA; Agrawal KC
    J Med Chem; 1982 Nov; 25(11):1342-6. PubMed ID: 7143372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitroheterocyclic drugs as selective radiosensitizers of hypoxic mammalian cells.
    Chapman JD; Reuvers AP; Borsa J; Henderson JS; Migliore RD
    Cancer Chemother Rep; 1974; 58(4):559-70. PubMed ID: 4853356
    [No Abstract]   [Full Text] [Related]  

  • 29. The in vitro interaction with DNA of several hypoxic radiosensitizers.
    Santos Peinado L; Cornago Ramirez P; Lopez Zumel C
    Chem Biol Interact; 1989; 71(2-3):245-53. PubMed ID: 2598300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Synergetic radiosensitizing effect of isomers S-8932 and S-8933 in vitro].
    Mi FS
    Zhonghua Zhong Liu Za Zhi; 1993 Mar; 15(2):94-6. PubMed ID: 8166889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of sensitizers on cell respiration: III. The effects of hypoxic cell radiosensitizers on oxidative metabolism and the radiation response of an in vitro tumour model.
    Durand RE; Biaglow JE; Greenstock CL
    Br J Cancer Suppl; 1978 Jun; 3():150-3. PubMed ID: 277215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and evaluation of alpha-[[(2-haloethyl)amino]methyl]-2- nitro-1H-imidazole-1-ethanols as prodrugs of alpha-[(1-aziridinyl)methyl]-2- nitro-1H-imidazole-1-ethanol (RSU-1069) and its analogues which are radiosensitizers and bioreductively activated cytotoxins.
    Jenkins TC; Naylor MA; O'Neill P; Threadgill MD; Cole S; Stratford IJ; Adams GE; Fielden EM; Suto MJ; Stier MA
    J Med Chem; 1990 Sep; 33(9):2603-10. PubMed ID: 2391699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
    Palmer BD; Wilson WR; Anderson RF; Boyd M; Denny WA
    J Med Chem; 1996 Jun; 39(13):2518-28. PubMed ID: 8691449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiosensitization of EMT6 cells by four platinum complexes.
    Teicher BA; Rockwell S; Lee JB
    Int J Radiat Oncol Biol Phys; 1985 May; 11(5):937-41. PubMed ID: 4039304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The radiosensitizing effects of hypoxic cell sensitizer on SCCVII tumors in mice evaluated by highly accurate colony formation assay assisted by microcomputer.
    Ono K; Akuta K; Masunaga S; Kinashi Y; Suzuki M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Dec; 56(14):1066-70. PubMed ID: 9014470
    [No Abstract]   [Full Text] [Related]  

  • 36. Nitrotriazoles bearing sulfur-substituted side chains: preparation and characterization as hypoxic cell radiosensitizers.
    Sugita T; Masuoka M; Nishikawa Y; Nishimoto S; Zhou L; Sasai K; Kagiya T
    Anticancer Drug Des; 1992 Jun; 7(3):277-84. PubMed ID: 1610484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical radiosensitizers for use in radiotherapy.
    Wardman P
    Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):397-417. PubMed ID: 17478086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiosensitizing ability and cytotoxicity of some 5(4)-substituted 2-methyl-4(5)-nitroimidazoles.
    Wideł M; Watras J; Suwiński J; Salwińska E
    Neoplasma; 1982; 29(4):407-15. PubMed ID: 7133232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiosensitization by acetohydroxamic acid derivatives of 3-nitropyrazole.
    Mulcahy RT; Wustrow DJ; Hark RR; Kende AS
    Radiat Res; 1986 Mar; 105(3):296-306. PubMed ID: 3961096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, in vitro cytotoxicity and radiosensitizing activity of novel 3-[(2,4-dinitrophenylamino)alkyl] derivatives of 5-fluorouracil.
    Khalaj A; Abdi K; Ostad SN; Khoshayand MR; Lamei N; Nedaie HA
    Chem Biol Drug Des; 2014 Feb; 83(2):183-90. PubMed ID: 23964692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.